For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Growth Hormone Secretagogues

Sermorelin

Also known as: Geref

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the 44-aa native hormone — the shortest fragment that retains full biological activity. It was FDA-approved in the 1990s as Geref (EMD Serono) for diagnostic testing of pituitary GH reserve and later for pediatric idiopathic GH deficiency, but was withdrawn from the US market in 2008–2009 at the manufacturer's request for commercial reasons (not safety or efficacy). It remains on the FDA Category 1 list of bulk substances nominated for use in 503A compounding, where it is now widely prescribed off-label for adult GH insufficiency and "anti-aging" indications.

Real-time market data

Pricing for Sermorelin

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$8.02/mg

range $0.06–$25.00/mg

Sellers

65

from $0.00

45-day trend

-11.7%

vs 45-day avg $/mg

57 of 65 sellers have a current price· 36 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for Sermorelin

116 third-party tests across 23 vendors. Each card links to the full report.

All 116 COAs for Sermorelin →
Measured purity 98.3%–100.0% across 75 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.57 %
Jul 2026
ILS Labs Strong

For

Sermorelin

by NG Peptide· batch SM10-05

Aggregated · 3rd-party listing
99.93 %
Jun 2026
ILS Labs Strong

For

Sermorelin

by NG Peptide· batch sm10-05

Aggregated · 3rd-party listing
98.98 %
Jun 2026
ILS Labs Strong

For

Sermorelin

by Crush Research· batch CR-SMLN-10MG-2605-1

Aggregated · 3rd-party listing
99.67 %
May 2026
Freedom Diagnostics Moderate

For

Sermorelin

by Profound Aminos· batch Grey Cap

Aggregated · 3rd-party listing
99.55 %
May 2026
Freedom Diagnostics Moderate

For

Sermorelin

by Profound Aminos· batch Grey Cap

Aggregated · 3rd-party listing
99.49 %
May 2026
Freedom Diagnostics Moderate

For

Sermorelin

by Peptide Supply Co.· batch SM1005192026

Aggregated · 3rd-party listing
99.68 %
May 2026
ILS Labs Strong

For

SERMO

by Ion Peptide· batch SMO5-05072026

Aggregated · 3rd-party listing
99.66 %
May 2026
ILS Labs Strong

For

SERMO

by Ion Peptide· batch SMO5-05072026

Aggregated · 3rd-party listing
99.07 %
May 2026
Janoshik Analytical Limited

For

Sermorelin

by EZ Peptides· batch EZP-SER0505052026-05

✓ Vendor-published
99.07 %
May 2026
Janoshik Analytical Limited

For

Sermorelin

by EZ Peptides· batch EZP-SER0505052026-05

COA on file
✓ Vendor-published
99.04 %
May 2026
Vanguard Laboratory Strong

For

Sermorelin

by Licensed Peptides· batch Black Cap

COA on file
Aggregated · 3rd-party listing
99.41 %
May 2026
Freedom Diagnostics Moderate

For

Sermorelin

by Real Peptides· batch Black Cap

Aggregated · 3rd-party listing
99.91 %
Apr 2026
ILS Labs Strong

For

Sermorelin

by NG Peptide· batch SM10-04

Aggregated · 3rd-party listing
99.27 %
Apr 2026
Horizon Analytical

For

Sermorelin

by Pepsgpt· batch P-3758495-P

Aggregated · 3rd-party listing
99.66 %
Apr 2026
Janoshik Analytical Limited

For

Sermorelin

by Reta Peptide· batch 20260409

Aggregated · 3rd-party listing
99.00 %
Apr 2026
Ethos Analytics Strong · HPLC

For

Sermorelin

by OROS Research· batch OR-LPSERM5-426-B4

✓ Vendor-published
99.93 %
Apr 2026
Kovera Labs

For

Sermorelin

by Ion Peptide· batch SERM10-04072026

COA on file
✓ Vendor-published
99.94 %
Apr 2026
Kovera Labs

For

Sermorelin

by Peptide Partners· batch SER202601

COA on file
Aggregated · 3rd-party listing
99.94 %
Mar 2026
Kovera Labs

For

Sermorelin

by Ion Peptide· batch SERM10-03232026

✓ Vendor-published
99.94 %
Mar 2026
Kovera Labs

For

Sermorelin

by Ion Peptide· batch SERM10-03232026

COA on file
Aggregated · 3rd-party listing
99.20 %
Mar 2026
Freedom Diagnostics Moderate

For

Sermorelin

by Kimera Chems· batch KC-SEM-GRN1

Aggregated · 3rd-party listing
99.98 %
Mar 2026
Kovera Labs

For

Sermorelin

by Glacier Aminos· batch SER10GA-02

Aggregated · 3rd-party listing
99.80 %
Feb 2026
Janoshik Analytical Limited · HPLC

For

Sermorelin

by Prime Peptides· batch 01222026SR

Aggregated · 3rd-party listing
99.80 %
Feb 2026
Vanguard Laboratory Strong

For

Sermorelin

by Peptidology· batch 1669

Research depth

20 citations indexed for Sermorelin

All research on Sermorelin →

review · 2026

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

Performance-enhancing drugs (PEDs) marketed as "research compounds" include unregulated peptides intended to modulate the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.

review · 2026

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.

review · 2026

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review

The pursuit of pharmacological enhancement in sport has evolved from the widespread use of anabolic-androgenic steroids (AAS) to novel agents such as peptides and peptide analogues.

Study · 2026

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry

Growth hormone-releasing hormone (GHRH) and its synthetic analogs are considered performance-enhancing substances and are therefore prohibited by the World Anti-Doping Agency (WADA).

review · 2026

Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications

Background Injectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory consensus.

review · 2026

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.